Santa Rosa, CA, United States of America

Scott R Forsberg

USPTO Granted Patents = 3 

Average Co-Inventor Count = 4.0

ph-index = 2

Forward Citations = 8(Granted Patents)


Company Filing History:


Years Active: 2018-2023

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Scott R Forsberg: Innovator in Grape Seed Products for Liver Health

Introduction

Scott R Forsberg is an accomplished inventor based in Santa Rosa, CA (US). He has made significant contributions to the field of health and nutrition, particularly through his innovative use of grape seed products. With a total of 3 patents, Forsberg's work focuses on promoting liver health and addressing nonalcoholic fatty liver disease (NAFLD).

Latest Patents

Forsberg's latest patents include groundbreaking uses of grape products. One of his notable inventions is related to Sauvignon blanc grape seed products for nonalcoholic fatty liver disease. This patent describes various embodiments that utilize grape products, such as Chardonnay grape products and grape seed flour, to promote a healthy liver and treat or prevent NAFLD. Another significant patent involves Pinot noir grape products, which similarly aim to enhance liver health and manage fat content in the liver.

Career Highlights

Throughout his career, Scott R Forsberg has worked with various organizations, including Sonomaceuticals, LLC and the United States of America, as represented by the Secretary of Agriculture. His innovative approach to health and nutrition has garnered attention and respect in the industry.

Collaborations

Forsberg has collaborated with notable individuals in his field, including Torey James Arvik and Hyunsook Kim. These partnerships have contributed to the advancement of his research and the development of his patented products.

Conclusion

Scott R Forsberg's contributions to the field of health through his innovative grape seed products highlight his commitment to improving liver health. His patents reflect a significant advancement in the treatment and prevention of nonalcoholic fatty liver disease.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…